MEREO BIOPHARMA 2 LIMITED

09647035
Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
M

MEREO BIOPHARMA 2 LIMITED

09647035

Research and experimental development on biotechnology

Founded 18 Jun 2015 Active London, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 11 Jul 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 30 Jun 2025 Next due 2 Jul 2026 8 days remaining
Net assets £813K £128K 2024 year on year
Total assets £813K £245K 2024 year on year
Total Liabilities £0 £117K 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

4th Floor, One Cavendish Place London W1G 0QF England

Full company profile for MEREO BIOPHARMA 2 LIMITED (09647035), an active company based in London, England. Incorporated 18 Jun 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

N/A

Net Assets

£813.04k

Decreased by £128.28k (-14%)

Total Liabilities

N/A

Decreased by £116.58k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 11 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Charles Edward SermonDirectorBritishUnited Kingdom5730 Jun 2015Active
Christine Ann FoxDirectorAmericanUnited Kingdom466 Jan 2021Active
Denise Vera Scots-knightDirectorBritishEngland6718 Jun 2015Active

Shareholders

Shareholders (1)

Mereo Biopharma Group Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MEREO BIOPHARMA 2 LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
1 Jul 2025OfficersChange to director Dr Denise Vera Scots-Knight on 5 Mar 2025
30 Jun 2025Confirmation StatementConfirmation statement made on 18 Jun 2025 with no updates
20 Mar 2025OfficersChange to director Dr Denise Vera Scots-Knight on 5 Mar 2025
1 Oct 2024AccountsAnnual accounts made up to 31 Dec 2023
11 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

1 Jul 2025 Officers

Change to director Dr Denise Vera Scots-Knight on 5 Mar 2025

30 Jun 2025 Confirmation Statement

Confirmation statement made on 18 Jun 2025 with no updates

20 Mar 2025 Officers

Change to director Dr Denise Vera Scots-Knight on 5 Mar 2025

1 Oct 2024 Accounts

Annual accounts made up to 31 Dec 2023

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

11 months ago on 11 Jul 2025

Change to director Dr Denise Vera Scots-Knight on 5 Mar 2025

11 months ago on 1 Jul 2025

Confirmation statement made on 18 Jun 2025 with no updates

11 months ago on 30 Jun 2025

Change to director Dr Denise Vera Scots-Knight on 5 Mar 2025

1 years ago on 20 Mar 2025

Annual accounts made up to 31 Dec 2023

1 years ago on 1 Oct 2024